Abigail Stevenson, DPhil

Associate Director, Market Access and Outcomes Strategy

DPhil (Oxon) Clinical Science (Cancer Cell Biology)
University of Oxford, Oxford, UK

BSc (Hons) Biochemistry with Applied Molecular Biology
University of Manchester Institute of Science and Technology (UMIST), Manchester, UK

Abigail Stevenson, DPhil, is an Associate Director in the Market Access and Outcomes Strategy group and is based in RTI-HS’s office in Manchester, UK. In her current role, Dr. Stevenson is involved in primary and secondary research to develop evidence-based dossiers, payer value communication toolkits, systematic and targeted literature reviews, health technology assessment submissions and health economics and outcomes research strategies. She has experience in a broad range of therapy areas, including diabetes, obesity, endocrinology, hematology and medical devices. Prior to joining RTI-HS, Dr. Stevenson was a Technical Analyst at the National Institute for Health and Care Excellence (NICE), specialising in the evaluation of medical devices and diagnostic tests for use in the UK’s National Health Service (NHS).